ADMA Biologics Inc vs Chipotle Mexican Grill, Inc. — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Chipotle Mexican Grill, Inc. trades at $32.71 (market cap $40.49B). The key difference: Chipotle Mexican Grill, Inc. is far larger — about 18.2× ADMA Biologics Inc's market cap, and Chipotle Mexican Grill, Inc. is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | CMG | |
|---|---|---|
Market Cap | $2.22B | $40.49B |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $44.04 |
52-Week Low | $7.60 | $28.17 |
Enterprise Value | $2.29B | $45.24B |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Read more on CMG →